(Q73718725)
Statements
Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis (English)
Jurgen C Becker
Dirk Schadendorf
Michael Weichenthal
Bernd-Rudiger Balda
Helmut H Wolff
Wolfgang Tilgen
Klaus-Werner Schulte
Johannes Ring
Stephan Lischner
Gunter Burg
Reinhard Dummer